Great Point Partners’s Viridian Therapeutics VRDN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-750,000
| Closed | -$10.1M | – | 36 |
|
|
2025
Q1 | $10.1M | Hold |
750,000
| – | – | 5.36% | 5 |
|
|
2024
Q4 | $14.4M | Hold |
750,000
| – | – | 6.78% | 4 |
|
|
2024
Q3 | $17.1M | Buy |
750,000
+250,000
| +50% | +$5.69M | 5.02% | 5 |
|
|
2024
Q2 | $6.51M | Sell |
500,000
-835,000
| -63% | -$10.9M | 1.25% | 25 |
|
|
2024
Q1 | $23.4M | Buy |
+1,335,000
| New | +$23.4M | 3.64% | 9 |
|